Page last updated: 2024-11-04

sb 202190 and Leukemia P388

sb 202190 has been researched along with Leukemia P388 in 1 studies

4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujihara, M1
Ikebuchi, K1
Maekawa, TL1
Wakamoto, S1
Ogiso, C1
Ito, T1
Takahashi, TA1
Suzuki, T1
Sekiguchi, S1

Other Studies

1 other study available for sb 202190 and Leukemia P388

ArticleYear
Lipopolysaccharide-induced desensitization of junB gene expression in a mouse macrophage-like cell line, P388D1.
    Journal of immunology (Baltimore, Md. : 1950), 1998, Oct-01, Volume: 161, Issue:7

    Topics: Animals; Benzoquinones; Calcium-Calmodulin-Dependent Protein Kinases; Dose-Response Relationship, Im

1998